Related Experiment Video
Updated: Nov 23, 2025

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
Published on: March 29, 2019
Divergent molecular profile of PIK3CA gene in arsenic-associated bladder carcinoma
Mukta Basu1, Balarko Chakraborty1, Sabnam Ghosh2
1Department of Oncogene Regulation, Chittaranjan National Cancer Institute, Kolkata, India.
Abstract:
The activation of PIK3CA in bladder carcinoma (BlCa) with its recurrent mutations in exon 9 and 20 were well reported. But the association of arsenic on the activation of the pathway is not well elucidated. Therefore, we aimed to analyse the effect of arsenic on the genetic (copy number variation/mutation) and expression profiles of PIK3CA in primary BlCa samples. Infrequent amplification (16%) of the PIK3CA locus was observed, with higher frequency among the arsenic-high (AsH) than arsenic-low (AsL) samples. Frequent (54%) tumour-specific mutations in exon 9 and 20 of PIK3CA were observed in the BlCa samples with prevalent (47%) C>T transition mutations. Exon 9 and 20 harboured 48% and 73% of the total mutations, respectively, with 37% in E542K/E545K and 25% of the mutation in H1047Y/R. Though mutation frequency in AsH and AsL was found to be comparable, we observed some arsenic-specific mutation at c.1633G>A, c.1634A>C (E545K) and c.2985C>T and c.3130G>T mutations, as well as prevalent transverse mutations of A>C and G>T in AsH group. Furthermore, 73% of the BlCa samples showed overexpression (mRNA/protein) of PIK3CA with genetic alterations (amplification/mutation), significantly (P = 0.01) higher in AsH group. However, 36% of the samples showed overexpressed PIK3CA, independent of mutation or amplification, signifying a transcriptional upregulation of PIK3CA gene. Therefore, the expression status of NFκB, a transcription factor of PIK3CA, was assessed and found to be significantly correlated with the overexpression of PIK3CA (mRNA/protein) in AsH group. Similarly, the expression pattern of pAKT1 (Thr 308) was also found to be significantly correlated with PIK3CA overexpression. Finally, AsH patients with the overexpression of PIK3CA or NFκB had the worst overall survival, signifying a strong impact of arsenic on this pathway and outcome of the patients. Thus, our study showed that the arsenic-associated differential molecular profile of PIK3CA/AKT1/NFkB in BlCa has an important role in the molecular pathogenesis of the disease.
Insights
Arsenic exposure influences PIK3CA gene alterations and overexpression in bladder cancer, impacting patient survival. This highlights arsenic
Area of Science:
- Oncology
- Environmental Health
- Molecular Biology
Background:
- PIK3CA mutations are common in bladder carcinoma (BlCa).
- The role of arsenic in PIK3CA pathway activation in BlCa is unclear.
Purpose of the Study:
- To investigate the effect of arsenic exposure on PIK3CA genetic and expression profiles in primary BlCa.
- To understand the association between arsenic, PIK3CA alterations, and patient outcomes.
Main Methods:
- Analysis of PIK3CA copy number variation and mutations in bladder cancer samples.
- Assessment of PIK3CA mRNA and protein expression levels.
- Evaluation of NFκB and pAKT1 (Thr 308) expression.
- Correlation of molecular findings with arsenic exposure levels and patient survival data.
Main Results:
- Arsenic-high (AsH) samples showed increased PIK3CA locus amplification compared to arsenic-low (AsL) samples.
- Frequent PIK3CA mutations, particularly C>T transitions and transverse mutations, were observed, with some arsenic-specific mutations identified in AsH group.
- PIK3CA overexpression (mRNA/protein) was significantly higher in AsH group, linked to genetic alterations and NFκB/pAKT1 expression.
- Overexpression of PIK3CA or NFκB in AsH patients correlated with poorer overall survival.
Conclusions:
- Arsenic exposure is associated with distinct PIK3CA genetic and expression profiles in bladder cancer.
- The PIK3CA/AKT1/NFκB pathway is differentially modulated by arsenic, contributing to bladder cancer pathogenesis.
- Arsenic-induced molecular changes in this pathway significantly impact patient survival, underscoring environmental risk factors in cancer development.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
09:24In Vitro Scratch Assay to Demonstrate Effects of Arsenic on Skin Cell Migration
Published on: February 23, 2019